Literature DB >> 22258480

Improving survival in a large French ALS center cohort.

Paul H Gordon1, François Salachas, Gaelle Bruneteau, Pierre-François Pradat, Lucette Lacomblez, Jesus Gonzalez-Bermejo, Capucine Morelot-Panzini, Thomas Similowski, Alexis Elbaz, Vincent Meininger.   

Abstract

The aim of this work was to determine whether survival changed during 2002-2009 at a French amyotrophic lateral sclerosis (ALS) center. We included all patients with ALS who were seen consecutively at the center from January 2002-May 2009. Participants were followed from date of first visit through death, date of censoring, or December 31, 2009, whichever occurred first. Cox proportional hazard models computed hazard ratios (HR; 95% confidence interval CI) of death, and flexible modeling of continuous predictors (splines) assessed trends in survival. We analyzed a total of 2,037 ALS patients, of whom 1,471 died before the end of follow-up. Median survival was 2.83 years from onset and 1.65 years from first visit. Compared to patients first seen before 2004, the HR of death was 0.97 (95% CI = 0.85-1.11, p = 0.6721) for patients first seen in 2004-2005, 0.96 (95% CI = 0.83-1.10, p = 0.5125) for 2006-2007, and 0.56 (95% CI = 0.46-0.69, p < 0.0001) after 2007, while adjusting for other survival predictors. Spline analysis confirmed that survival remained stable during 2002-2006, then markedly improved. The proportion of patients receiving non-invasive ventilation (NIV) increased from 16 (2004) to 51% (2008). At this large ALS center, survival improved after 2006. Because more aggressive use of NIV was the principal therapeutic adaptation, our data suggest that better survival resulted from improved respiratory care.

Entities:  

Mesh:

Year:  2012        PMID: 22258480     DOI: 10.1007/s00415-011-6403-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Safety and factors related to survival after percutaneous endoscopic gastrostomy in ALS. ALS Percutaneous Endoscopic Gastrostomy Study Group.

Authors:  A Chiò; E Finocchiaro; P Meineri; E Bottacchi; D Schiffer
Journal:  Neurology       Date:  1999-09-22       Impact factor: 9.910

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Objective measures of the efficacy of noninvasive positive-pressure ventilation in amyotrophic lateral sclerosis.

Authors:  L S Aboussouan; S U Khan; M Banerjee; A C Arroliga; H Mitsumoto
Journal:  Muscle Nerve       Date:  2001-03       Impact factor: 3.217

4.  Choice of time-scale in Cox's model analysis of epidemiologic cohort data: a simulation study.

Authors:  Anne C M Thiébaut; Jacques Bénichou
Journal:  Stat Med       Date:  2004-12-30       Impact factor: 2.373

5.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.

Authors:  Stephen C Bourke; Mark Tomlinson; Tim L Williams; Robert E Bullock; Pamela J Shaw; G John Gibson
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

6.  The natural history of ALS is changing: improved survival.

Authors:  Muddasir Qureshi; David A Schoenfeld; Yuvika Paliwal; Amy Shui; Merit E Cudkowicz
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

7.  Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?

Authors:  Adam Czaplinski; Albert A Yen; Ericka P Simpson; Stanley H Appel
Journal:  Arch Neurol       Date:  2006-08

8.  Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

Authors:  B J Traynor; M Alexander; B Corr; E Frost; O Hardiman
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-09       Impact factor: 10.154

Review 9.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 10.  Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues.

Authors:  G Logroscino; B J Traynor; O Hardiman; A Chio'; P Couratier; J D Mitchell; R J Swingler; E Beghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-01       Impact factor: 10.154

View more
  8 in total

Review 1.  Clinical neurogenetics: amyotrophic lateral sclerosis.

Authors:  Matthew B Harms; Robert H Baloh
Journal:  Neurol Clin       Date:  2013-11       Impact factor: 3.806

2.  Coordinated care affects hospitalization and prognosis in amyotrophic lateral sclerosis: a cohort study.

Authors:  Valérie Cordesse; Florence Sidorok; Priscilla Schimmel; Josiane Holstein; Vincent Meininger
Journal:  BMC Health Serv Res       Date:  2015-04-02       Impact factor: 2.655

3.  Survival and Cause of Death among a Cohort of Confirmed Amyotrophic Lateral Sclerosis Cases.

Authors:  Susan T Paulukonis; Eric M Roberts; Jhaqueline P Valle; Natalie N Collins; Paul B English; Wendy E Kaye
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

4.  Multi-parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis.

Authors:  Mohamed-Mounir El Mendili; Julien Cohen-Adad; Mélanie Pelegrini-Issac; Serge Rossignol; Régine Morizot-Koutlidis; Véronique Marchand-Pauvert; Caroline Iglesias; Sina Sangari; Rose Katz; Stéphane Lehericy; Habib Benali; Pierre-François Pradat
Journal:  PLoS One       Date:  2014-04-22       Impact factor: 3.240

5.  Predicting disease progression in amyotrophic lateral sclerosis.

Authors:  Albert A Taylor; Christina Fournier; Meraida Polak; Liuxia Wang; Neta Zach; Mike Keymer; Jonathan D Glass; David L Ennist
Journal:  Ann Clin Transl Neurol       Date:  2016-09-07       Impact factor: 4.511

Review 6.  Maximizing the Survival of Amyotrophic Lateral Sclerosis Patients: Current Perspectives.

Authors:  Osama A Khairoalsindi; Ahmad R Abuzinadah
Journal:  Neurol Res Int       Date:  2018-08-12

7.  Sensitivity of Awaji Criteria and Revised El Escorial Criteria in the Diagnosis of Amyotrophic Lateral Sclerosis (ALS) at First Visit in a Tunisian Cohort.

Authors:  Bademain Jean Fabrice Ido; Imen Kacem; Mahamadi Ouedraogo; Amina Nasri; Saloua Mrabet; Amina Gargouri; Mouna Ben Djebara; Bawindsongré Jean Kabore; Riadh Gouider
Journal:  Neurol Res Int       Date:  2021-01-22

8.  A Bayesian computational model for online character recognition and disability assessment during cursive eye writing.

Authors:  Julien Diard; Vincent Rynik; Jean Lorenceau
Journal:  Front Psychol       Date:  2013-11-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.